Plain-English translation of NCT07164950 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether medical-grade compression stockings can help prevent peripheral neuropathy—a type of nerve damage that causes tingling, numbness, and pain in the hands and feet—in patients receiving antibody-drug conjugates (ADCs) for advanced cancers like urothelial carcinoma. You would wear a compression stocking on one foot during your cancer treatment while leaving the other foot uncovered, allowing researchers to compare how well the stocking protects against nerve damage.
Antibody-drug conjugates are effective cancer treatments, but they often cause painful nerve damage in the feet and hands as a side effect. Researchers want to see if compression stockings—which improve blood flow and reduce stress on nerves—might prevent or reduce this damage and help patients maintain their quality of life during treatment.
You likely qualify if…
You likely don't qualify if…
You would visit the study center before starting cancer treatment, then wear a medical compression stocking on one foot (randomly assigned) starting 15 minutes before each medication infusion and continuing for 2 hours total—while your other foot goes uncovered as a comparison. Over 24 months, you'll have check-ins after your third treatment cycle, within a week after finishing treatment, and one month later, where researchers will examine your feet, measure temperature, and ask you about any numbness, tingling, or pain using standard questionnaires.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China